Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

EGFR inhibitors for lung cancer can cause severe skin issues.

Minoxidil and a solvent mixture can prevent hair loss caused by chemotherapy in mice.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

A topical lotion helped manage hair loss from chemotherapy by affecting cell death, inflammation, and collagen, with no side effects.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Pantethine may boost the immune system's ability to fight sarcoma.

Nanoparticles improve cancer treatment by reducing side effects and targeting cancer cells better.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

TPA is about 50 times more effective at promoting tumors than MZ.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Different treatments for skin conditions were found to be effective and generally safe, with biologics recommended as the first choice for generalized pustular psoriasis.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.